ThinkSono | AI DVT Detection

Reach us

Company

Quick Links

Legal

Modern Slavery Statement

Carbon Reduction Plan

Trust Center

Regulatory Approval & Compliance

ThinkSono Guidance is currently only CE IIb marked for clinical use in the EU and UK. It is not FDA approved. Please contact ThinkSono for more information. The CE Class IIb intended purpose of ThinkSono Guidance is found in the instructions for use (IFU). ThinkSono Guidance EU manufacturer is ThinkSono GmbH (EUDAMED SRN number: DE-MF-000034914). To buy and use ThinkSono Guidance please send an email to hello@thinksono.com

Reach us

Company

Quick Links

Legal

Modern Slavery Statement

Carbon Reduction Plan

Trust Center

Regulatory Approval & Compliance

ThinkSono Guidance is currently only CE IIb marked for clinical use in the EU and UK. It is not FDA approved. Please contact ThinkSono for more information. The CE Class IIb intended purpose of ThinkSono Guidance is found in the instructions for use (IFU). ThinkSono Guidance EU manufacturer is ThinkSono GmbH (EUDAMED SRN number: DE-MF-000034914). To buy and use ThinkSono Guidance please send an email to hello@thinksono.com

Reach us

Company

Quick Links

Legal

Modern Slavery Statement

Carbon Reduction Plan

Trust Center

Regulatory Approval & Compliance

ThinkSono Guidance is currently only CE IIb marked for clinical use in the EU and UK. It is not FDA approved. Please contact ThinkSono for more information. The CE Class IIb intended purpose of ThinkSono Guidance is found in the instructions for use (IFU). ThinkSono Guidance EU manufacturer is ThinkSono GmbH (EUDAMED SRN number: DE-MF-000034914). To buy and use ThinkSono Guidance please send an email to hello@thinksono.com

News & PR

News & PR

News & PR

Featured news

The world’s first Ultrasound AI software for blood clots obtains EU Approval

ThinkSono Partners With NYU Langone Health to Conduct Study of Ultrasound AI Guidance Software for DVT Detection

Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection

All News

AI-assisted ultrasound helps most suspected blood clot patients receive a clinical decision within 30 minutes at Chelsea and Westminster Hospital

ThinkSono Receives FDA Clearance for Ultrasound AI Software for Blood Clots

ThinkSono selected in the UK’s top 100 AI scale ups

ThinkSono Obtains FDA Breakthrough Device Designation

ThinkSono Raises $6M — What’s next?

ThinkSono Secures Additional £4.5M / $6Mn Funding, Expands Team and Operations Across the UK, EU and U.S.

UW Health - Clinical study tests AI-guided ultrasound to detect deep vein thrombosis

Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients

Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection

Fouad Noor presents ThinkSono at LSI Europe 2023

Regulatory Approval & Compliance

Regulatory Approval & Compliance

Regulatory Approval & Compliance